Tofacitinib Registry of Patients With Ulcerative Colitis in Germany - Documentation of Tofacitinib Induction and Maintenance Therapy in Conjunction With Long-term Outcome and Predictors of Response
Latest Information Update: 12 Oct 2021
Price :
$35 *
At a glance
- Drugs Tofacitinib (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms TOFA-UC
- 30 Sep 2021 Status changed from recruiting to discontinued as not enough patients recruited, Study objective could not be achieved.
- 17 Feb 2020 Status changed from not yet recruiting to recruiting.
- 26 Jul 2019 New trial record